← Evidence map

ArticleOncoTargets and therapy2010

Survivin-T34A: molecular mechanism and therapeutic potential.

Jonathan R Aspe et al.PubMed ↗Full text ↗Publisher ↗

No numbers read from the abstract.

26 papers cite it

2010
2011
2012
2013
2014
2015
2016
2017
2018
2019
2020
2021
2022
2023
this papercites it
Full record →Abstract, authors, funding and every citing paper · PMID 21289859